Approval · Notice of Compliance 3473 · 2003
ELAVIL PLUS: Notice of Compliance 3473
Issued March 7, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3473
- Date
- March 7, 2003
- Company
- Triton Pharma Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antidepressant, neuroleptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELAVIL PLUS | 00253200 | Cancelled Post Market |
Medicinal ingredients
- AMITRIPTYLINE HCL 25 MG per TAB
- PERPHENAZINE 2 MG per TAB